HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 35 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $54 | – | 180 | +3500.0% | 0.00% | – |
| Q3 2022 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 5 | -100.0% | 0.00% | – |
| Q4 2021 | $35,000 | -28.6% | 31,149 | -2.7% | 0.00% | – |
| Q3 2021 | $49,000 | +2350.0% | 32,004 | +3935.8% | 0.00% | – |
| Q2 2021 | $2,000 | -99.1% | 793 | -99.4% | 0.00% | – |
| Q1 2021 | $228,000 | – | 123,654 | +2472980.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 5 | -100.0% | 0.00% | – |
| Q3 2020 | $103,000 | – | 33,215 | +664200.0% | 0.00% | – |
| Q2 2020 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 5 | -54.5% | 0.00% | – |
| Q3 2019 | $0 | – | 11 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 57,309 | $178,000 | 0.03% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 15,552 | $48,000 | 0.00% |
| Squarepoint Ops LLC | 15,524 | $48,000 | 0.00% |
| ExodusPoint Capital Management, LP | 11,632 | $36,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 33,215 | $103,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 57 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 15,786 | $49,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 29,233 | $91,000 | 0.00% |
| MORGAN STANLEY | 54 | $0 | 0.00% |